Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of identifying compounds that interfere with ERG-driven misguidance of BAF complexes in TMPRSS2-ERG driven prostate cancers

Methods of identifying compounds that interfere with ERG-driven misguidance of BAF complexes in TMPRSS2-ERG driven prostate cancers

US Patent 12282014 · Granted Apr 22, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

SWI/SNF family chromatin remodeling complexes and uses thereof2025
Cyclopentaimidazolones for the treatment of cancer2024
Methods of treating cancer having an active Wnt/β-catenin pathway2024
Compositions and methods for targeting cancer-specific sequence variations2022
Methods for identifying and treating cancer patients2021
Compounds and methods for treating synovial sarcomas2020
Methods of treating cancer having an active Wnt/β-catenin pathway2019
Methods, compositions and screens for therapeutics for the treatment of synovial2018
Signatures and determinants associated with cancer and methods of use thereof2017
Methods, compositions and screens for therapeutics for the treatment of synovial2016
Phosphorylated RaIA2014
Compositions and methods for identifying transforming and tumor suppressor genes2012